Stanford University: Lymphoma trials

The registry lists 30 Lymphoma studies with Stanford University as lead sponsor. 3 are open to participants now and 12 have results posted.

Phase 1 8Phase 2 15No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell LymphomasRecruitingNCT06340737Phase 1
• Pediatric PET/MR Image RegistryRecruitingNCT03458520
• Bone Marrow Grafting for Leukemia and LymphomaEnrolling by invitationNCT00186147
• Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell TransplantationCompletedNCT03734601Phase 2Results posted
• Ipilimumab and Local Radiation for Selected Solid TumorsTerminatedNCT01769222Phase 1Results posted
• Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCTTerminatedNCT01220297Phase 2Results posted
• Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis FungoidesTerminatedNCT01187446Phase 1/2Results posted
• Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis FungoidesTerminatedNCT00985140Results posted
• Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell LymphomaCompletedNCT00896493Phase 2Results posted
• Study of Bexxar <Tositumomab> Combined With External Beam Radiation TherapyTerminatedNCT00490490Phase 2Results posted
• Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCTTerminatedNCT00482053Phase 2Results posted
• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's LymphomaTerminatedNCT00481832Phase 2Results posted
• Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's DiseaseCompletedNCT00388349Phase 2Results posted
• Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's LymphomaCompletedNCT00225212Phase 2Results posted
• Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's LymphomaCompletedNCT00026208Phase 2Results posted
• 18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in LymphomaTerminatedNCT05096234Phase 1
• Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
• Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid SequencingTerminatedNCT01556828
• Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host DiseaseCompletedNCT01155817Phase 1
• Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRTTerminatedNCT01144754
• Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody TreatmentCompletedNCT00398372Not applicable
• 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHLCompletedNCT00186589Phase 1
• High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's LymphomaCompletedNCT00186394Phase 2
• Enrichment & Purging of Stem Cells in Non-Hodgkin's LymphomaCompletedNCT00186355Not applicable
• Allo BMT in Advanced Leukemia or High Grade LymphomaCompletedNCT00186290Not applicable
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's LymphomaCompletedNCT00055783Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaCompletedNCT00006009Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression TherapyCompletedNCT00003716Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's LymphomaCompletedNCT00002715Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's DiseaseCompletedNCT00002714Phase 2